openPR Logo
Press release

With 4.56% CAGR, Urinary Tract Infection Therapeutics Market Size Worth USD 11,652 million by 2027 - Comprehensive Research Report by Facts & Factors

11-07-2022 09:50 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Facts & Factors

Urinary Tract Infection Therapeutics Market

Urinary Tract Infection Therapeutics Market

Facts and Influences A new report from Market Research is titled "Urinary Tract Infection Therapeutics Market- By Age Group (Children, Adults & Elderly), By Indication (Complicated, Uncomplicated, Recurrent, Catheter-related), By Distribution Network (E-commerce, Hospital Pharmacies, Retail Pharmacies), By Drug Group (Azoles and Amphotericin B, Cephalosporin, Quinolones, Nitrofurans, Penicillin The global market for therapies for urinary tract infections was estimated to be worth USD 8,935 million in 2020 and is projected to grow to USD 11,652 million by 2027, with a CAGR of roughly 4.56% between 2021 and 2027.

Microbes are the primary cause of UTIs, or urinary tract infections. Most of these organisms are bacteria. UTIs can, however, also be brought on by viral and fungal infections. While UTIs can arise anywhere in the urinary tract, including the kidneys, uterus, bladder, and urethra, they typically affect the urethra and bladder. In contrast to UTIs that affect the lower tract, those that affect the upper tract-that is, the uterus and kidneys-occur less frequently but can be far more severe. Depending on the infection's source, different UTIs typically require a different approach to treatment. As a result, medications are prescribed by doctors and medical professionals based on the type of organism that caused the particular UTI.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ@https://www.fnfresearch.com/sample/urinary-tract-infection-therapeutics-market

๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐จ๐Ÿ ๐ฎ๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐ญ๐ซ๐š๐œ๐ญ ๐ข๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ฌ ๐ฉ๐ซ๐ข๐ฆ๐š๐ซ๐ข๐ฅ๐ฒ ๐๐ซ๐ข๐ฏ๐ž๐ง ๐›๐ฒ ๐ข๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐”๐“๐ˆ ๐ข๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž๐ฌ.

The market for urinary tract infection therapies is being driven by the rising frequency of urinary tract infections in men around the world. Due to their shorter urethras than men, women are more susceptible to UTIs. The most common form of bacteria that causes UTIs is E. Coli. The microorganisms that cause UTIs to enter the urethra and move up the bladder and kidneys, where they can cause harm to the person's health.

The growing older population worldwide, particularly those over 60, is another factor driving the market for urinary tract infection therapies. A urinary tract infection is considerably more likely to occur in the elderly population since they are more likely to have diabetes. Seniors frequently contract infections from hospitals.

๐“๐ก๐ž ๐ข๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐๐จ๐ฆ๐ข๐ง๐š๐ญ๐ž๐ ๐›๐ฒ ๐ฎ๐ง๐œ๐จ๐ฆ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ž๐ ๐”๐“๐ˆ.

In 2017, the market for simple UTIs was approximately USD 5,092 million. The most prevalent sort of UTIs now impacting the world's population is simple UTIs. Antibiotics are typically advised for the treatment of these UTIs. Due to the rise in hospital-acquired infections, including catheter-associated UTIs, the segment of urinary tract infections that are not complicated is projected to dominate the market for therapies in the year to come.

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ@https://www.fnfresearch.com/inquiry/urinary-tract-infection-therapeutics-market

๐“๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ž๐œ๐ญ๐จ๐ซ ๐ข๐ฌ ๐ก๐จ๐ฌ๐ฉ๐ข๐ญ๐š๐ฅ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ข๐ž๐ฌ.

The segment of urinary tract infection therapeutics is hospital pharmacies. In 2017, it brought in USD 5,323 million in income, and in the years to come, it is expected to increase quickly. Additionally, a respectable CAGR is projected for the retail pharmacy category internationally in the next years.

๐“๐จ๐ฉ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

๐Š๐ž๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐ฉ๐ž๐ซ๐š๐ญ๐ข๐ง๐  ๐ข๐ง ๐ญ๐ก๐ž ๐ฎ๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐ญ๐ซ๐š๐œ๐ญ ๐ข๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž Bristol-Myers Squibb Company, Cipla, C.H. Boehringer Sohn, Dr. Reddy's Laboratories Ltd., Achaogen, Allergen, Aquinox, AstraZeneca, Almirall, S.A, Bayer AG, F. Hoffmann-La Roche, GlaxoSmithKline plc., Janssen Global Services, LLC, Lipella Pharmaceuticals, Lupin Ltd., MediciNova, MerLion Pharmaceuticals, Merck & Co., Inc, Novo Nordisk, Novartis, Pfizer, Sun Pharmaceutical Industries, Shionogi, Teva Pharmaceutical Industries, Urigen, and Zavante Therapeutics, among others.

๐‘๐ž๐š๐ ๐›๐ฎ๐ฒ๐ง๐จ๐ฐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง@https://www.fnfresearch.com/buynow/su/urinary-tract-infection-therapeutics-market

๐“๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ ๐ญ๐ก๐ž ๐ฎ๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐ญ๐ซ๐š๐œ๐ญ ๐ข๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ฌ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ฌ:

๐Ž๐ง ๐ญ๐ก๐ž ๐›๐š๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐€๐ ๐ž ๐†๐ซ๐จ๐ฎ๐ฉ, ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ข๐ง๐ญ๐จ:

Children
Adults
Elderly

๐Ž๐ง ๐ญ๐ก๐ž ๐›๐š๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง, ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ข๐ง๐ญ๐จ:

Complicated
Uncomplicated
Recurrent
Catheter-related

๐Ž๐ง ๐ญ๐ก๐ž ๐›๐š๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐๐ž๐ญ๐ฐ๐จ๐ซ๐ค, ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ข๐ง๐ญ๐จ:

E-Commerce
Hospital Pharmacies
Retail Pharmacies

๐Ž๐ง ๐ญ๐ก๐ž ๐›๐š๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ƒ๐ซ๐ฎ๐  ๐†๐ซ๐จ๐ฎ๐ฉ, ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ข๐ง๐ญ๐จ:

Azoles and Amphotericin B
Cephalosporin
Quinolones
Nitrofurans
Penicillin and Combinations
Others

๐†๐ฅ๐จ๐›๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa

๐‘๐ž๐š๐ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง@https://www.fnfresearch.com/urinary-tract-infection-therapeutics-market

๐“๐ก๐ž ๐ฌ๐ญ๐ฎ๐๐ฒ ๐จ๐ง ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐Ÿ๐จ๐ซ ๐ฎ๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐ญ๐ซ๐š๐œ๐ญ ๐ข๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐ก๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ :

Market share and rival companies
Market organization: Overview
Growth factors and restrictions
Analysis of the Porter Five
SWOT evaluation
Market forecasts and trends
Market divisions and projections
newest trends
Development possibilities.

๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐€๐ฅ๐ฌ๐จ ๐„๐ฑ๐š๐ฆ๐ข๐ง๐ž๐ฌ:

Competitive businesses and producers in the worldwide market
Applications, Product Type, and Growth Factors
Current Situation and Future Prospects of the Major Applications, End Users, and Usage Area

๐“๐ก๐š๐ง๐ค๐ฌ ๐Ÿ๐จ๐ซ ๐ซ๐ž๐š๐๐ข๐ง๐  ๐ญ๐ก๐ข๐ฌ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ; ๐ฒ๐จ๐ฎ ๐œ๐š๐ง ๐š๐ฅ๐ฌ๐จ ๐ ๐ž๐ญ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐š๐ฅ ๐œ๐ก๐š๐ฉ๐ญ๐ž๐ซ-๐ฐ๐ข๐ฌ๐ž ๐ฌ๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ ๐จ๐ซ ๐ซ๐ž๐ ๐ข๐จ๐ง-๐ฐ๐ข๐ฌ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ฏ๐ž๐ซ๐ฌ๐ข๐จ๐ง๐ฌ ๐ฅ๐ข๐ค๐ž ๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š, ๐„๐ฎ๐ซ๐จ๐ฉ๐ž, ๐จ๐ซ ๐€๐ฌ๐ข๐š.

Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email:ย sales@fnfresearch.com
Web:ย https://www.fnfresearch.com

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client's/customer's conviction in our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release With 4.56% CAGR, Urinary Tract Infection Therapeutics Market Size Worth USD 11,652 million by 2027 - Comprehensive Research Report by Facts & Factors here

News-ID: 2794403 • Views: โ€ฆ

More Releases from Facts & Factors

Trending: Military Vehicle Electrification Market Size & Share To Exceed USD 9.5 Billion by 2026 | Facts and Factors
Trending: Military Vehicle Electrification Market Size & Share To Exceed USD 9.5 โ€ฆ
The Military Vehicle Electrification Market has developed swiftly in recent years and has made a significant contribution to the global financial situation in terms of growth rate, market share, and sales generation. The report titled Military Vehicle Electrification Market is an analytical study that presents a comprehensive explanation of the industry along with information on significant aspects of the market. Request Access Full Report is Available @ https://www.fnfresearch.com/military-vehicle-electrification-market This covers marketโ€ฆ
Global AIOps (Artificial Intelligence for IT Operations) Market - Size, Share, Growth, Trends and Forecasts 2026
Global AIOps (Artificial Intelligence for IT Operations) Market - Size, Share, G โ€ฆ
The research report presents a strategic analysis of the AIOps (Artificial Intelligence for IT Operations) Market analysis through top players, size, share, key drivers, challenges, opportunities, competitive landscape, market attractiveness analysis, new product launches, technological innovations, and growth contributors. Further, the market attractiveness index is provided based on a five-forces analysis. View the Full Report with Table of Contents @ https://www.fnfresearch.com/artificial-intelligence-for-it-operations-market This report mainly focuses on the top players and theirโ€ฆ
Exceptional Growth in Global Quantum Dot Solar Cell Market Size, Share to Gain USD 2,319.8 Million by 2026: Facts & Factors
Exceptional Growth in Global Quantum Dot Solar Cell Market Size, Share to Gain U โ€ฆ
The Quantum Dot Solar Cell Market has developed swiftly in recent years and has made a significant contribution to the global financial situation in terms of growth rate, market share, and sales generation. Request Access Full Report is Available @ https://www.fnfresearch.com/quantum-dot-solar-cell-market The report titled "Quantum Dot Solar Cell Market" is an analytical study that presents a comprehensive explanation of the industry along with information on significant aspects of the market. Thisโ€ฆ
Global Energy Meter Market Size, Share, Growth, Business Strategies and Forecast by 2026 | Exclusive Report by Facts & Factors
Global Energy Meter Market Size, Share, Growth, Business Strategies and Forecast โ€ฆ
The Energy Meter Market has developed swiftly in recent years and has made a significant contribution to the global financial situation in terms of growth rate, market share, and sales generation. Request Access Full Report is Available @ https://www.fnfresearch.com/energy-meter-market The report titled Energy Meter Market is an analytical study that presents a comprehensive explanation of the industry along with information on significant aspects of the market. This covers market demands, majorโ€ฆ

All 5 Releases


More Releases for UTI

Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl โ€ฆ
Introduction The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve. This article explores the key factors driving theโ€ฆ
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for โ€ฆ
Introduction Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven byโ€ฆ
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHLโ€ฆ
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE โ€ฆ
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc. Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders. Houston, TX based Patterson-UTIโ€ฆ
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report: The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individualsโ€ฆ
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMIโ€™s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tractโ€ฆ